Samir Kapadia, MD, is the chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic. He is a professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Kapadia is board-certified in internal medicine, cardiology, and interventional cardiology. 
 
Specialty/Clinical interests: Percutaneous treatment for valve disease, transcatheter aortic valve replacement (TAVR), Mitraclip, complex coronary interventions, atrial septal defect (ASD), and patent foramen ovale (PFO) closure, carotid interventions, peripheral interventions 
 
Number of Procedures Performed: Dr. Kapadia has performed 1,000 TAVR procedures and thousands of other cardiovascular procedures throughout his career. 
 
Success Rates: Cleveland Clinic is nationally and internationally renowned for the world’s best cardiovascular care. Success rates for specific procedures are available here.
 
Education and Training: Dr. Kapadia received his medical degree with honors from Smt. NHL Municipal Medical College in Gujarat, India. He completed his internship and residency in internal medicine at Baylor College of Medicine, Houston, where he was named Outstanding Resident. Dr. Kapadia completed cardiology and interventional cardiology fellowships at Cleveland Clinic, Cleveland, and was named chief interventional fellow. Dr. Kapadia was appointed to Cleveland Clinic in 2003 as a staff interventional cardiologist. 
 
Dr. Kapadia was appointed to Cleveland Clinic in 2003 as a staff interventional cardiologist. He served as the program director for the interventional cardiology fellowship (2005-16), director of Sones Cardiac Catheterization Laboratory (2009-19), and the section head of interventional cardiology (2015-19) before becoming the chairman of cardiovascular medicine in 2019.  
 
Before his appointment at the Cleveland Clinic, Dr. Kapadia had an academic appointment at the Department of Medicine at the University of Washington, Seattle, and was an interventional cardiologist at the VA Puget Sound Health Care System, Seattle. 
 
Research, Publications, and Speaking: Dr. Kapadia has published >1000 manuscripts on coronary, peripheral, and structural interventions indexed in PubMed with an H-index of 121 on Google Scholar and is recognized as one of the top 0.1% of highly cited researchers in the Web of Science. He spearheaded the research on stroke prevention in patients undergoing TAVR. He is currently the principal investigator in several clinical research trials, including research to investigate percutaneous methods to treat aortic stenosis and mitral regurgitation. Dr. Kapadia is specialized in complex coronary interventions and percutaneous treatments for valvular heart disease. 
 
Dr. Kapadia has authored two textbooks, the Textbook of Interventional Cardiology and Board Review for Cardiology. He has been invited to speak at hundreds of regional, national, and international symposiums and conferences. He has been involved in several guidelines and position papers on percutaneous treatment of valvular heart disease. 
 
Dr. Kapadia is also an innovator with more than 15 issued patents for devices to treat valvular heart diseases. 
 
About Dr. Kapadia: “I love getting to know the patients and families well so I can provide appropriate care and meet their expectations. Procedural expertise is necessary for the best outcomes but not enough; compassionate clinical care is an essential element that we should not ignore.” 
 
Leisure time activities: In his leisure time, Dr. Kapadia enjoys spending time with his family, astronomy, physics, and math.